Internship

Machine Learning Engineering Intern

Posted on 2/7/2025

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

Compensation Overview

$22.50 - $41.50/hr

No H1B Sponsorship

San Diego, CA, USA

This is preferred to be a hybrid role located at our ResMed office in San Diego, CA. Candidates will be asked to be available to participate in on-site team meetings.

Category
Applied Machine Learning
AI & Machine Learning
Required Skills
Kubernetes
Python
Data Science
Git
SQL
Machine Learning
Docker
AWS
Pandas
Scala
Terraform
Requirements
  • Ability to work full-time for 12 weeks during Summer 2025; program dates are May 19, 2025 – August 8, 2025 OR June 16, 2025 – September 5, 2025
  • Computer Science or Machine Learning academic studies that will lead to a Bachelor's or Master's Degree
  • Experience or self study in Scala, Kubernetes, Python, SQL, Pandas, AWS, Terraform, Docker, Github, general CI/CD practices
Responsibilities
  • Work with the team to build scalable AI/ML development and production systems which are able to handle big data throughput
  • Use leading-edge technologies in machine learning and cloud computing to train, serve and monitor AI/ML models in production
  • Work closely with MLEs, MLOps, Data Engineers, and Data Scientists to build and extend the global AI/ML platform
Desired Qualifications
  • Excellent critical thinking and problem-solving skills
  • Strong experiences as demonstrated through projects, research or Computer-Science/Machine-Learning internships
  • Great interpersonal relations, team cooperation and communication skills
  • Exceptional organizational and collaboration skills as demonstrated through leadership positions on teams and/or in student or civic organizations
  • Exceptional communication skills and interest and enthusiasm related to medical technology industry and a career with ResMed

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed serves patients, healthcare professionals, and caregivers, focusing on improving care and quality of life. Unlike many competitors, ResMed combines device sales with software subscriptions, creating a recurring revenue model. The company's goal is to reduce hospital visits and lower healthcare costs while providing effective solutions for chronic disease management.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing telehealth adoption boosts demand for ResMed's cloud-connected solutions.
  • The sleep apnea devices market is projected to grow at a 7.8% CAGR until 2028.
  • Rising chronic respiratory diseases increase demand for ResMed's COPD management solutions.

What critics are saying

  • Emerging startups in home sleep apnea testing could impact ResMed's market share.
  • AI-driven diagnostic advancements may outpace ResMed's current technology offerings.
  • Semiconductor shortages could delay production of ResMed's cloud-connected devices.

What makes Resmed unique

  • ResMed offers cloud-connected medical devices for sleep apnea and chronic disease management.
  • The company provides software platforms enhancing patient care and reducing healthcare costs.
  • ResMed operates in over 120 countries, ensuring a broad global reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.

Medtrade
Apr 4th, 2025
Resmed Launches New Home Sleep Apnea Test

SAN DIEGO - Medtrade exhibitor Resmed has launched NightOwl(TM), a new home sleep apnea test (HSAT) that is now available across the United States.

MPO Magazine
Apr 3rd, 2025
Resmed Launches NightOwl Home Sleep Apnea Test

Resmed has launched its NightOwl home sleep apnea test (HSAT) in the U.S.

MarketBeat
Feb 28th, 2025
Proficio Capital Partners LLC Invests $50.36 Million in ResMed Inc. (NYSE:RMD)

Proficio Capital Partners LLC invests $50.36 million in ResMed Inc. (NYSE:RMD).

Healthier Tomorrow
Feb 26th, 2025
ResMed Survey: Despite Sleep Problems, Few Willing to Take Proactive Steps

ResMed today unveiled the findings of its fifth annual Global Sleep Survey.

INACTIVE